ARCHIMED sells a majority stake in Ad-Tech to Nihon Kohden, yielding a 5x return on investment while entering a strategic joint-venture for growth in key markets.
Information on the Target
Ad-Tech is a notable entity within the medical technology sector, recognized for its innovative contributions to electronic medical devices. The company specializes in the development and distribution of advanced solutions that enhance medical procedural efficiency and patient outcomes. With a commitment to cutting-edge technology and robust product offerings, Ad-Tech has secured a significant market presence internationally.
By leveraging its core capabilities, Ad-Tech has not only expanded its product lines but also established itself as a pivotal player in the medical electronic equipment space. The recent investment has catalyzed further enhancements and expansions, positioning the company for sustained success in various global markets.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Japan
The medical technology industry in Japan is one of the most advanced globally, characterized by continuous innovation and significant investment in research and development. As one of the largest markets for me
Similar Deals
Nihon Kohden
invested in
Ad-Tech
in 2023
in a Joint Venture deal